$RKLB

Rocket Lab Stock Tumbles After Q2 Earnings Misses Estimate

Rocket Lab (RKLB) shares fell about 2% after Q2 results. The company reported revenue of $234M, up 62% year over year and slightly above estimates, but an adjusted loss of 8 cents per share was worse than expected. Q3 GAAP gross margin guidance was 29% to 31%, below consensus. Investors also weighed margin pressure from satellite platform mix and questions about Rocket Lab’s planned $8B Iridium acquisition.

Original reporting
Published Aug 11, 2026, 4:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 4:41 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Rocket Lab Stock Tumbles After Q2 Earnings Misses Estimate — source image
Decision brief

The 30-second read

$RKLBBearishMed
01

Why it matters

Near-term valuation and positioning may shift toward margin durability and acquisition-related dilution, even with strong demand signals like backlog.

02

Market read

This is a company-specific earnings and guidance-driven repricing, with the margin outlook and acquisition dilution as the core debate.

03

What to watch

The article notes satellite platform mix as a margin headwind and includes backlog and Neutron progress, which could support a rebound if guidance is viewed as mix-driven rather than demand-driven.

Relevance 8/10Novelty 6/10Timing: post-close reaction Tuesday, after Q2 earnings and Q3 guidance

Background

Rocket Lab reported Q2 revenue growth but missed on profitability and guided to lower GAAP gross margins for Q3, while also discussing its planned Iridium acquisition.

Company-level read

Ticker impact

$RKLBBearishHigh confidence
Context

Rocket Lab shares fell after Q2 results showed an adjusted loss wider than expected and weaker third-quarter GAAP gross-margin guidance.

Expected impact

Bearish near-term bias, with follow-through risk if investors continue to reprice margin trajectory and acquisition dilution.

Evidence & confidence

The article cites specific Q2 and Q3 guidance datapoints (adjusted loss, GAAP gross margin range) plus a concrete acquisition-related dilution figure reflected in guidance.

Market effects

Highlights investor sensitivity to margin trajectory in commercial space, not just revenue growth.

No specific regional impact described.

Limited to global commercial space profitability expectations and acquisition-dilution concerns.

Counterpoint

Revenue growth and a record backlog plus Neutron progress may offset margin concerns if investors focus on longer-cycle execution rather than near-term gross margin.

Key entities

  • Rocket Lab

    Space company whose Q2 results and Q3 gross-margin guidance drove the stock drop; also tied to the planned Iridium acquisition.

  • Iridium

    Target of Rocket Lab’s planned $8 billion acquisition, potentially increasing dilution reflected in guidance.

Related articles

$RKLBMed

Rocket Lab’s $2.36 Billion Backlog Says the Neutron Delay Doesn’t Matter — Here’s Why

Rocket Lab (NASDAQ:RKLB) reported record Q2 revenue of $234 million, up 62% year over year, and said its backlog rose to $2.36 billion after securing over $1 billion in Q2 new awards. CEO Peter Beck cited a narrowing Neutron launch window. The company also expects a pending Iridium (NASDAQ:IRDM) deal adding about $870 million in annual revenue; analysts raised a price target to $122 from $96.

$RKLBMedAI 8/10

Rocket Lab Q2 2026 earnings: revenue up 62%, loss widens

Rocket Lab reported Q2 2026 revenue of $234 million, up 62% year over year, but a wider net loss of $49.3 million, or 8 cents per share, versus $66.4 million a year earlier. FactSet forecasts cited by The Wall Street Journal expected a 6-cent loss. Revenue mix rose in product sales to $181.3 million. Backlog was $2.36 billion. Q3 revenue guidance was $250-$265 million.

$RIOTHighAI 8/10

Riot, NIQ surge, On Holding tumbles premarket

U.S. stock futures were mostly flat as investors weighed geopolitical uncertainty and awaited U.S. inflation data. In premarket earnings moves, Riot Platforms rose on a $9.1B AI data center contract with Anthropic, NIQ Global Intelligence beat and raised guidance, On Holding fell on weaker sales, and Rocket Lab dropped on margin guidance.

$RKLBMedAI 8/10

Rocket Lab revenue hits a record US$234 million while the losses keep coming

Rocket Lab reported record Q2 revenue of US$234.1 million, up 62% year over year, with gross profit rising to US$84.6 million and gross margin to 36.1%. It posted a net loss of US$49.3 million. Backlog rose to US$2.36 billion. Guidance for Sept quarter: revenue US$250-265 million; adjusted loss US$17-23 million; gross margin 29-31%. Shares fell after results.

$RKLBMed

Rocket Lab USA, Hims & Hers, AST SpaceMobile, Archer Aviation and Plug Power: Why These 5 Stocks Are on I

U.S. indices fell Monday. The article highlights five stocks: Rocket Lab (down 3.37% to $80.04) ahead of Q2 results; analysts expect an 8-cent loss on $231.1M revenue, with a $397M Space Force contract. Hims & Hers (up 0.57% to $31.77) raised 2026 revenue guidance to $3.1B-$3.3B. AST SpaceMobile (down 4.42% to $68.76) missed Q2 revenue and reaffirmed 2026 outlook. Archer Aviation (up 11.99% to $6.26) reported Q2 revenue $5M and $1.56B cash. Plug Power (down 3.21% to $2.11) beat Q2 estimates and

$RKLBHighAI 9/10

Rocket Lab revenue climbs 62% as backlog reaches record $2.36 billion

Rocket Lab reported Q2 revenue of $234.1 million, up 62% year over year, driven by product sales rising to $181.3 million. Gross profit increased to $84.6 million and gross margin to about 36%. Backlog hit a record $2.36 billion. The company forecast Q3 revenue of $250 million to $265 million and expects an adjusted EBITDA loss of $17 million to $23 million.